Built and exited before
Deep IVD experience, with regulatory, AI, and finance coverage across the leadership team.
Leadership
Sanjeev Saxena
Serial entrepreneur; former CEO of POC Medical Systems, Vice Chairman of Texas Tech Research Park, and former founding CEO & Chairman of Actis Biologics.
Bradley Morgan
10+ years in senior IVD leadership roles, including business development at POC Medical Systems and venture & corporate finance experience.
Eric Wilkinson
Founder/co-founder of DNA Sciences, Synthetic Genetics, Genetic Vectors, and XLTechGroup; research leadership at Diversa and IDEC (Biogen).
Tony Huey
Seasoned executive and former management consultant; former POC Medical Systems executive with finance and operational leadership experience.
Dr. Nitin Malekar
30+ years of management and commercial experience in India; former President, POC Medical Systems India.
Engineering & Regulatory Team
Ali Muckadam
Experienced hardware & electrical engineer with expertise across FPGA, SoC, and systems design.
Dr. Okyaz Eminaga
MD/PhD and postdoctoral research instructor in AI at Stanford.
Ayan Neogi
20+ years of clinical & regulatory management experience, including at POC Medical Systems India.
Rabeek Mohamed
Engineering lead supporting instrument and platform development.
Shivanshu Gupta
Leads data analysis supporting AI model development and validation.
Aaron Maloney
Software engineering leadership across the Harae Dx product suite.
Technical & Business Advisory Board
Experts in AI, microfluidics, assay development, biotechnology, and business development who guide our mission.
Dr. Marc Madou
Distinguished Professor, Mechanical & Aerospace Engineering.
Marc Goldberg
Founding Partner / Co-founder & Managing Partner.
Dr. Andrea Cuppoletti
Seasoned executive and scientist; former VP R&D, POC Medical Systems.
Christie Wang
Partner and Board Director; serial entrepreneur and early medtech investor.
Jaydipkumar Patel
Serial entrepreneur; Founder & CEO, IDHS Group.
Dr. Ehsan Irajizad
Assistant Professor, Department of Biostatistics, Division of Discovery Science.
Investors
Key shareholders backing Harae Dx’s mission to close the breast cancer detection gap.